Go back to the Europarl portal

Choisissez la langue de votre document :

  • bg - български
  • es - español
  • cs - čeština
  • da - dansk
  • de - Deutsch
  • et - eesti keel
  • el - ελληνικά
  • en - English (Selected)
  • fr - français
  • ga - Gaeilge
  • hr - hrvatski
  • it - italiano
  • lv - latviešu valoda
  • lt - lietuvių kalba
  • hu - magyar
  • mt - Malti
  • nl - Nederlands
  • pl - polski
  • pt - português
  • ro - română
  • sk - slovenčina
  • sl - slovenščina
  • fi - suomi
  • sv - svenska
Parliamentary questions
PDF 102kWORD 18k
28 September 2018
Question for written answer E-004948-18
to the Commission
Rule 130
José Blanco López (S&D)

 Subject:  Homeopathy
 Answer in writing 

The Spanish Government advised the Commission recently that it should amend legislation in force on homeopathy. Directive 2001/83/EC on the Community code relating to medicinal products for human use lays down that: ‘The essential aim of any rules governing the production, distribution or use of medicinal products must be to safeguard human health’.

The Spanish Government takes a different view to the directive, viewing homeopathic products as medicinal products, but at the same time it believes the public is confused about the properties of the products and that this constitutes an ever more serious risk to consumers’ health.

1. Has the Commission received similar notifications from other Member States concerning the advisability of amending current legislation?

2. Does it plan to change the current definitions in Directive 2001/83/EC of ‘medicinal product’ and ‘homeopathic medicinal product’ and approve a standardised regulatory framework that would clarify the situation for both health professionals and the public?

3. Will it prohibit advertisements proclaiming the effectiveness, safety and quality of homeopathic medicines for which no demonstrable evidence that can be replicated exists?

Original language of question: ES 
Last updated: 9 October 2018Legal notice